Literature DB >> 8357624

Suprasellar masses: diagnosis and differential diagnosis.

B L Hershey1.   

Abstract

Suprasellar masses are neoplastic, vascular, congenital, or infectious/inflammatory in origin. Magnetic resonance imaging (MRI) is the study of choice for evaluating suprasellar masses, although computed tomography (CT) may provide complementary information. Suprasellar masses present with a variety of neurologic or endocrine dysfunctions depending on their site of origin and mass effect on adjacent structures. Imaging characteristics of the most common suprasellar lesions are described with particular emphasis on MR findings.

Entities:  

Mesh:

Year:  1993        PMID: 8357624     DOI: 10.1016/s0887-2171(05)80082-4

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  6 in total

Review 1.  Neuroendocrine imaging.

Authors:  D J Seidenwurm
Journal:  AJNR Am J Neuroradiol       Date:  2008-03       Impact factor: 3.825

2.  MR imaging characteristics of amyloid deposits in pituitary adenoma.

Authors:  Steven W Martin; Daniel R Lefton; Richard S Pinto; Marc Rosenblum; Eric Elowitz
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

3.  A Case of Langerhans Cell Histiocytosis Manifested as a Suprasellar Mass.

Authors:  Ju Young Yoon; Byung-Kiu Park; Heon Yoo; Sang Hyun Lee; Eun Kyung Hong; Weon Seo Park; Young Joo Kwon; Jong Hyung Yoon; Hyeon Jin Park
Journal:  Brain Tumor Res Treat       Date:  2016-04-29

4.  Pituitary apoplexy in a pregnant woman.

Authors:  Vijay Parihar; Y R Yadav; Dhananjaya Sharma
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

5.  Confounding features of ectopic craniopharyngioma: A differential for tumors showing diffusion restriction.

Authors:  Sudha Karnan; Vanitha Krishnamoorthy; Kailasanathan Natarajan; Babu Peter Sathyanathan
Journal:  Asian J Neurosurg       Date:  2017 Jan-Mar

6.  Differentiation of suprasellar meningiomas from non-functioning pituitary macroadenomas by 18F-FDG and 13N-Ammonia PET/CT.

Authors:  Lei Ding; Fangling Zhang; Qiao He; Zhoulei Li; Xinchong Shi; Ruocheng Li; Xiangsong Zhang
Journal:  BMC Cancer       Date:  2020-06-17       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.